23rd October 2019
The article first appeared on Macclesfield Express
A DIABETES research company can expand its offering after raising £400,000 online. Gendius, based at Alderley Park, will now develop a mobile phone app called Intellin after reaching its target on crowdfunding platform Crowdcube.
The app takes an individual’s clinical history and tells them their risk of developing complications from their diabetes and how to manage these. Rory Cameron, chief executive officer at the company, said: “Our mission is to ensure that every person with diabetes understands their risk of complications and how to manage them. “The NHS alone spends over £11 billion a year on diabetes and 80 per cent of these costs are avoidable and linked to the complications.
“The personal impact of diabetes is huge with the disease leading to blindness, kidney failure, amputation, heart attack and/ or stroke.
“The number of adults living with diabetes has almost quadrupled since 1980 to 422 million adults and this will reach 629 million by 2045.”
“We are looking to offer the app to the NHS via the NHS app store and through pilots with GP practices. We are also making the app available both free and via a monthly charge (pro version) on the app stores.”
Gendius is looking to expand its presence in Europe and launch in the USA, Middle East and South East Asia.
The app will also gather personal and disease-specific information that enables the program to identify the user’s personal areas of risk.
Rory added: “For instance if you have had a previous foot ulcer then it makes sense that looking after your feet should be a priority.
“It sounds simple and that is the point, we want people to understand and manage their disease in bite sized chunks.”
Find out more at www.crowdcube.com/gendius